AstraZeneca's (AZN.UK) shares fell as much as 9.2% and touched their lowest level since April. However buyers managed to halt declines at 74.22 level and price bounced off. Currently stock is testing resistance at 77.67 which previously acted as a support. If buyers manage to break above it, an upward impulse towards major resistance at 82.20 could be launched. This level is additionally strengthened by 50 SMA (green line) and 200 SMA (red line). On the other hand, failure to break higher could see the stock pull back towards aforementioned support at 74.22 area. Source: xStation5US OPEN: Anthropic filing and Iran talks support the market
Anthropic files prospectus ahead of IPO with "ANT" ticker on Nasdaq. The launch date and price remain a mystery
Musk Borrows $40 Billion for AI and Warns Rivals: Neocloud Providers Could Face Serious Trouble
Three markets to watch next week (23.10.2026)